Genmab A (GMAB) EBITDA Margin (2018 - 2026)
Genmab A (GMAB) reported EBITDA Margin of 11.83% for Q1 2026, down 4092.0% on a YoY basis from 0.3% in Q1 2025, and down 129.71% quarter-over-quarter from 39.82% in Q3 2025.
Genmab A (GMAB) EBITDA Margin (2018 - 2026) Analysis & Trends
Genmab A has reported EBITDA Margin for 6 years, with the latest figure at 11.83% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin fell 4092.0% year-over-year to 11.83%; the trailing twelve-month figure through Mar 2026 stood at 23.83% (down 689.0% YoY), and the FY2025 full-year result was 28.63%, down 251.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 11.83%, down from 39.82% in the prior quarter.
- The five-year high for EBITDA Margin was 39.82% in Q3 2025, with the low at 11.83% in Q1 2026.
- Historically, EBITDA Margin has averaged 26.79% across 3 years, with a median of 33.0% in 2024.
- Annual changes were most pronounced in 2025 — EBITDA Margin soared 1444 bps — and 2026, when it plunged 4092 bps.
- Genmab A's EBITDA Margin stood at 38.6% in 2024, then increased by 3 bps to 39.82% in 2025, then sank by 130 bps to 11.83% in 2026.
- The last three EBITDA Margin figures came in at 11.83% (Q1 2026), 39.82% (Q3 2025), and 36.65% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -6.43% |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Genmab A | 48.34 Bn | 46.82 Bn | 831.00 Mn | -11.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.83% |
| Sep 30, 2025 | 39.82% |
| Jun 30, 2025 | 36.65% |
| Mar 31, 2025 | 29.09% |
| Sep 30, 2024 | 38.60% |
| Jun 30, 2024 | 22.21% |
| Mar 31, 2024 | 33.00% |
| Sep 30, 2020 | 0.00% |
| Dec 31, 2019 | 52.12% |
| Sep 30, 2019 | 52,096,564.48% |
| Dec 31, 2018 | 30.11% |